IDEXX Laboratories Basic Shares Outstanding 2010-2025 | IDXX
IDEXX Laboratories annual/quarterly basic shares outstanding history and growth rate from 2010 to 2025. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
- IDEXX Laboratories basic shares outstanding for the quarter ending March 31, 2025 were $0.081B, a 2.14% decline year-over-year.
- IDEXX Laboratories basic shares outstanding for the twelve months ending March 31, 2025 were $0.329B, a 1.09% decline year-over-year.
- IDEXX Laboratories annual basic shares outstanding for 2024 were $0.082B, a 0.72% decline from 2023.
- IDEXX Laboratories annual basic shares outstanding for 2023 were $0.083B, a 0.67% decline from 2022.
- IDEXX Laboratories annual basic shares outstanding for 2022 were $0.084B, a 1.85% decline from 2021.
| IDEXX Laboratories Annual Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2024 | $82 |
| 2023 | $83 |
| 2022 | $84 |
| 2021 | $85 |
| 2020 | $85 |
| 2019 | $86 |
| 2018 | $87 |
| 2017 | $88 |
| 2016 | $90 |
| 2015 | $93 |
| 2014 | $100 |
| 2013 | $106 |
| 2012 | $110 |
| 2011 | $114 |
| 2010 | $115 |
| 2009 | $118 |
| IDEXX Laboratories Quarterly Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2025-03-31 | $81 |
| 2024-12-31 | $82 |
| 2024-09-30 | $82 |
| 2024-06-30 | $83 |
| 2024-03-31 | $83 |
| 2023-12-31 | $83 |
| 2023-09-30 | $83 |
| 2023-06-30 | $83 |
| 2023-03-31 | $83 |
| 2022-12-31 | $84 |
| 2022-09-30 | $83 |
| 2022-06-30 | $84 |
| 2022-03-31 | $84 |
| 2021-12-31 | $85 |
| 2021-09-30 | $85 |
| 2021-06-30 | $85 |
| 2021-03-31 | $86 |
| 2020-12-31 | $85 |
| 2020-09-30 | $85 |
| 2020-06-30 | $85 |
| 2020-03-31 | $85 |
| 2019-12-31 | $86 |
| 2019-09-30 | $86 |
| 2019-06-30 | $86 |
| 2019-03-31 | $86 |
| 2018-12-31 | $87 |
| 2018-09-30 | $87 |
| 2018-06-30 | $87 |
| 2018-03-31 | $87 |
| 2017-12-31 | $88 |
| 2017-09-30 | $88 |
| 2017-06-30 | $88 |
| 2017-03-31 | $88 |
| 2016-12-31 | $90 |
| 2016-09-30 | $90 |
| 2016-06-30 | $90 |
| 2016-03-31 | $90 |
| 2015-12-31 | $93 |
| 2015-09-30 | $92 |
| 2015-06-30 | $93 |
| 2015-03-31 | $94 |
| 2014-12-31 | $100 |
| 2014-09-30 | $99 |
| 2014-06-30 | $102 |
| 2014-03-31 | $103 |
| 2013-12-31 | $106 |
| 2013-09-30 | $105 |
| 2013-06-30 | $107 |
| 2013-03-31 | $109 |
| 2012-12-31 | $110 |
| 2012-09-30 | $110 |
| 2012-06-30 | $110 |
| 2012-03-31 | $110 |
| 2011-12-31 | $114 |
| 2011-09-30 | $113 |
| 2011-06-30 | $115 |
| 2011-03-31 | $115 |
| 2010-12-31 | $115 |
| 2010-09-30 | $115 |
| 2010-06-30 | $115 |
| 2010-03-31 | $116 |
| 2009-12-31 | $118 |
| 2009-09-30 | $117 |
| 2009-06-30 | $118 |
| 2009-03-31 | $118 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $41.462B | $3.898B |
| IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $199.191B | 87.25 |
| Thermo Fisher Scientific (TMO) | United States | $152.413B | 18.44 |
| Edwards Lifesciences (EW) | United States | $45.596B | 29.90 |
| Alcon (ALC) | Switzerland | $42.592B | 28.78 |
| DexCom (DXCM) | United States | $33.274B | 51.43 |
| IQVIA Holdings (IQV) | United States | $24.396B | 13.66 |
| Mettler-Toledo (MTD) | United States | $24.382B | 29.00 |
| STERIS (STE) | Ireland | $24.071B | 26.54 |
| Waters (WAT) | United States | $21.144B | 29.83 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.666B | 0.00 |
| Hologic (HOLX) | United States | $14.021B | 15.23 |
| Sysmex ADR (SSMXY) | Japan | $10.468B | 29.70 |
| Penumbra (PEN) | United States | $10.283B | 80.71 |
| Masimo (MASI) | United States | $8.511B | 31.39 |
| Globus Medical (GMED) | United States | $7.972B | 19.00 |
| Glaukos (GKOS) | United States | $5.421B | 0.00 |
| Teleflex (TFX) | United States | $5.414B | 8.94 |
| TransMedics (TMDX) | United States | $4.319B | 93.89 |
| Integer Holdings (ITGR) | United States | $4.169B | 21.84 |
| PROCEPT BioRobotics (PRCT) | United States | $3.082B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.354B | 14.02 |
| Veracyte (VCYT) | United States | $2.111B | 29.63 |
| Elekta AB (EKTAY) | Sweden | $2.106B | 18.93 |
| Nihon Kohden (NHNKY) | Japan | $2.054B | 23.56 |
| Alphatec Holdings (ATEC) | United States | $1.821B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.417B | 0.00 |
| Artivion (AORT) | United States | $1.269B | 118.84 |
| Pulse Biosciences (PLSE) | United States | $1.200B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.985B | 5.24 |
| SiBone (SIBN) | United States | $0.809B | 0.00 |
| IRadimed (IRMD) | United States | $0.739B | 37.51 |
| Beta Bionics (BBNX) | United States | $0.666B | 0.00 |
| RxSight (RXST) | United States | $0.660B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.594B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.585B | 9.09 |
| Mesa Laboratories (MLAB) | United States | $0.571B | 13.38 |
| AxoGen (AXGN) | United States | $0.496B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.494B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.447B | 11.89 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.442B | 0.00 |
| NeuroPace (NPCE) | United States | $0.430B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.406B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.369B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.335B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.312B | 0.00 |
| Neuronetics (STIM) | United States | $0.260B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 13.94 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| 908 Devices (MASS) | United States | $0.210B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.182B | 0.00 |
| CVRx (CVRX) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.176B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.164B | 0.00 |
| Accuray (ARAY) | United States | $0.163B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.163B | 0.00 |
| LENSAR (LNSR) | United States | $0.162B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.148B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.138B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.098B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.70 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.066B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Hyperfine (HYPR) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Spectral AI (MDAI) | United States | $0.042B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.025B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.37 |